CC
ABMD

Cognios Capital’s Abiomed Inc ABMD Stock Holding History

Cognios Capital’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-9,704
Closed -$1.41M – 225
2020
Q1 		$1.41M Sell
9,704
-743
-7% -$123K 0.7% 59
2019
Q4 		$1.78M Buy
10,447
+566
+6% +$105K 0.63% 89
2019
Q3 		$1.76M Buy
+9,881
New +$2.14M 0.65% 90

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Cognios Capital's ABMD Position: Q2 2020 in Review

Cognios Capital sold out of Abiomed Inc (ABMD) in Q2 2020, closing a stake of 9,704 shares — an estimated $1.41M sold.

Cognios Capital first reported a position in ABMD in Q3 2019 and held it in 3 quarters. The position peaked at $1.78M in Q4 2019. 460 funds tracked by Wall St. Rank hold ABMD as of Q2 2020.

  • Cognios Capital reported no remaining Abiomed Inc position as of Q2 2020 after selling out during the quarter.
  • Cognios Capital sold 9,704 Abiomed Inc shares in Q2 2020, an estimated $1.41M.
  • Cognios Capital first reported a position in Abiomed Inc in Q3 2019 and held it in 3 quarters.
  • Cognios Capital's Abiomed Inc position peaked at $1.78M in Q4 2019.
  • 460 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2020.

Based on Cognios Capital's 13F filing for Q2 2020.